BIOPHARM FORWARD ApS: Financial statements 2015
CVR: 32438784
Source: annual report 2015, Danish Business Authority
26/08/2014 – 25/08/2015
BIOPHARM FORWARD ApS (CVR 32438784) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -1,776 and a net result of DKK -1,772 compared with DKK -2,214 the year before. Equity in the 2015 report amounted to DKK -25,327.
- Gross Profit
- DKK -1,776
- Profit/Loss
- DKK -1,772
- Equity
- DKK -25,327
- Total Assets
- DKK 968
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -2 t. | -2 t. | -25 t. | - |
| 2014 | - | -2 t. | -2 t. | -24 t. | - |
| 2013 | - | -2 t. | -2 t. | -21 t. | - |
| 2012 | - | -11 t. | -47 t. | -19 t. | - |
Official annual report
How creditworthy is BIOPHARM FORWARD ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
BIOPHARM FORWARD ApS has published its annual report for 2014. Gross profit came to DKK -2,222, and the net result was DKK -2,214.
About BIOPHARM FORWARD ApS
BIOPHARM FORWARD ApS is a Danish company of the type Anpartsselskab based in Espergærde, founded in 2009. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jonas Hink. The company is owned by Jonas Hink. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK 997,234 and a net result of DKK 243,660 compared with DKK 385,061 the year before. Equity in the 2025 report amounted to DKK 1,741,315.